{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-112331","form_type":"8-K","ticker":"KYNB","cik":"0000921299","company_name":"KYNTRA BIO, INC.","filed_at":"2024-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.395986+00:00","generated_at":"2026-05-30T21:58:13.041653+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"FibroGen terminates headquarters lease, accelerates expiration to Dec 31, 2024, with $10M settlement","bullets":["Entered Lease Termination Agreement with landlord ARE-San Francisco No.43 Owner, LLC.","Lease at 409 Illinois Street, San Francisco, ends Dec 31, 2024 (previously later date).","$10M settlement includes past rent, operating costs, lease modification payment, and security deposit (LC).","FibroGen not responsible for further rent or operating costs after termination."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-112331","json":"https://secwatch.observer/filing/0000950170-24-112331.json","markdown":"https://secwatch.observer/filing/0000950170-24-112331.md","text":"https://secwatch.observer/filing/0000950170-24-112331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921299/000095017024112331/0000950170-24-112331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921299/000095017024112331/fgen-20240927.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T21:58:13.041653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}